129 related articles for article (PubMed ID: 29088711)
21. HER2-driven breast cancer suppression by the JNK signaling pathway.
Itah Z; Chaudhry S; Raju Ponny S; Aydemir O; Lee A; Cavanagh-Kyros J; Tournier C; Muller WJ; Davis RJ
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2218373120. PubMed ID: 36656864
[TBL] [Abstract][Full Text] [Related]
22. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species.
Giambra V; Jenkins CR; Wang H; Lam SH; Shevchuk OO; Nemirovsky O; Wai C; Gusscott S; Chiang MY; Aster JC; Humphries RK; Eaves C; Weng AP
Nat Med; 2012 Nov; 18(11):1693-8. PubMed ID: 23086478
[TBL] [Abstract][Full Text] [Related]
23. Zebrafish krüppel-like factor 4a represses intestinal cell proliferation and promotes differentiation of intestinal cell lineages.
Li IC; Chan CT; Lu YF; Wu YT; Chen YC; Li GB; Lin CY; Hwang SP
PLoS One; 2011; 6(6):e20974. PubMed ID: 21687630
[TBL] [Abstract][Full Text] [Related]
24. The schizophrenia risk gene Map2k7 regulates responding in a novel contingency-shifting rodent touchscreen gambling task.
Openshaw RL; Pratt JA; Morris BJ
Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 35275161
[TBL] [Abstract][Full Text] [Related]
25. Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium.
Ghaleb AM; Aggarwal G; Bialkowska AB; Nandan MO; Yang VW
Mol Cancer Res; 2008 Dec; 6(12):1920-7. PubMed ID: 19074836
[TBL] [Abstract][Full Text] [Related]
26. Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation.
Fujikawa J; Tanaka M; Itoh S; Fukushi T; Kurisu K; Takeuchi Y; Morisaki I; Wakisaka S; Abe M
Cell Tissue Res; 2014 Oct; 358(1):177-87. PubMed ID: 24927920
[TBL] [Abstract][Full Text] [Related]
27. Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.
Openshaw RL; Thomson DM; Penninger JM; Pratt JA; Morris BJ
Psychopharmacology (Berl); 2017 Jan; 234(2):293-305. PubMed ID: 27774567
[TBL] [Abstract][Full Text] [Related]
28. Kruppel-Like Factor 4 represses osteoblast differentiation via ciliary Hedgehog signaling.
Takeuchi Y; Kito A; Itoh S; Naruse H; Fujikawa J; Sadek KM; Akiyama S; Yamashiro T; Wakisaka S; Abe M
Exp Cell Res; 2018 Oct; 371(2):417-425. PubMed ID: 30193838
[TBL] [Abstract][Full Text] [Related]
29. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression.
Liu Y; Sinha S; McDonald OG; Shang Y; Hoofnagle MH; Owens GK
J Biol Chem; 2005 Mar; 280(10):9719-27. PubMed ID: 15623517
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for producing selective MAP2K7 inhibitors.
Murakawa Y; Valter S; Barr H; London N; Kinoshita T
Bioorg Med Chem Lett; 2020 Nov; 30(22):127546. PubMed ID: 32931911
[TBL] [Abstract][Full Text] [Related]
31. miR‑92a represses the viability and migration of nerve cells in Hirschsprung's disease by regulating the KLF4/PI3K/AKT pathway.
Ji CY; Yuan MX; Chen LJ; Gao HQ; Zhang T; Yin Q
Acta Neurobiol Exp (Wars); 2022; 82(3):336-346. PubMed ID: 36214716
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Hong H; Sun X; Jiang H; Ma S; Zhao S; Zhang M; Wang Z; Jiang C; Liu H
Am J Cancer Res; 2016; 6(2):141-56. PubMed ID: 27186392
[TBL] [Abstract][Full Text] [Related]
33. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
[TBL] [Abstract][Full Text] [Related]
34. Kruppel-like factor 4 regulates developmental angiogenesis through disruption of the RBP-J-NICD-MAML complex in intron 3 of Dll4.
Boriushkin E; Zhang H; Becker M; Peachey J; Shatat MA; Adams RH; Hamik A
Angiogenesis; 2019 May; 22(2):295-309. PubMed ID: 30607695
[TBL] [Abstract][Full Text] [Related]
35. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
Song Y; Liu Y; Chen X
Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
[TBL] [Abstract][Full Text] [Related]
36. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
37. KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene.
Roberts MS; Anstine LJ; Finke VS; Bryson BL; Webb BM; Weber-Bonk KL; Seachrist DD; Majmudar PR; Keri RA
Breast Cancer Res; 2020 Jun; 22(1):66. PubMed ID: 32552913
[TBL] [Abstract][Full Text] [Related]
38. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma.
Sui C; Zhuang C; Sun D; Yang L; Zhang L; Song L
Oncotarget; 2017 Jul; 8(28):45837-45847. PubMed ID: 28507277
[TBL] [Abstract][Full Text] [Related]
39. Notch1 represses osteogenic pathways in aortic valve cells.
Nigam V; Srivastava D
J Mol Cell Cardiol; 2009 Dec; 47(6):828-34. PubMed ID: 19695258
[TBL] [Abstract][Full Text] [Related]
40. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
